Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$5.42
+3.0%
$4.54
$2.25
$7.99
$137.89M0.53222,641 shs83,973 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$0.45
-1.7%
$0.38
$0.13
$0.99
$12.10M0.29183,959 shs139,387 shs
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
$1.14
+2.3%
$1.17
$0.85
$2.00
$29.43M0.81177,834 shs52,264 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-3.49%+12.03%+14.10%+18.47%-7.56%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-3.97%-31.34%+39.39%+109.09%-5.74%
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
-4.31%-2.63%-4.31%-10.48%-25.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3.9855 of 5 stars
3.55.00.00.03.84.20.6
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.699 of 5 stars
0.03.00.00.03.72.50.0
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
2.0024 of 5 stars
3.55.00.00.02.20.00.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3.00
Buy$18.50241.33% Upside
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
3.00
Buy$2.2093.83% Upside

Current Analyst Ratings

Latest NMTC, DCTH, and GCTK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2024
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.07M66.61N/AN/A$0.72 per share7.53
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A$0.15 per shareN/A
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
$1.95M15.09N/AN/A$0.26 per share4.37

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$47.68M-$2.97N/AN/AN/A-2,308.86%-563.60%-111.13%5/27/2024 (Estimated)
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$7.10M-$0.37N/AN/AN/A-172.38%-127.42%5/10/2024 (Estimated)
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
-$11.86M-$0.68N/AN/A-478.41%-267.82%-200.46%5/9/2024 (Estimated)

Latest NMTC, DCTH, and GCTK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$0.10-$0.10-$0.10N/AN/A
3/26/2024Q4 23
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.67-$0.48+$0.19-$0.48$0.48 million$0.54 million    
2/13/2024Q1 2024
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
N/A-$0.14-$0.14-$0.14N/A$0.98 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
2.26
2.06
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.06
3.22
3.22
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
N/A
3.68
2.52

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
16.07%

Insider Ownership

CompanyInsider Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
17.94%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
17.70%
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
7.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
7625.44 million20.88 millionOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
626.76 million22.02 millionNot Optionable
NeuroOne Medical Technologies Co. stock logo
NMTC
NeuroOne Medical Technologies
1625.93 million23.99 millionOptionable

NMTC, DCTH, and GCTK Headlines

SourceHeadline
NeuroOne® Announces First Implant of OneRF(TM) Ablation ElectrodesNeuroOne® Announces First Implant of OneRF(TM) Ablation Electrodes
stockhouse.com - April 11 at 2:46 PM
NeuroOne® CEO Dave Rosa Featured on Bloomberg TechnologyNeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
globenewswire.com - April 10 at 9:00 AM
NeuroOne implants first OneRF ablation electrodeNeuroOne implants first OneRF ablation electrode
massdevice.com - April 9 at 2:44 PM
NeuroOne® Announces First Implant of OneRF™ Ablation ElectrodesNeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
globenewswire.com - April 9 at 9:05 AM
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
finance.yahoo.com - April 4 at 9:06 AM
NeuroOne® CEO Dave Rosa Featured on Fox Business Networks Varney & Co.NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
globenewswire.com - April 4 at 9:00 AM
NeuroOne® Initiates Limited Commercial Launch of OneRF(TM) Ablation SystemNeuroOne® Initiates Limited Commercial Launch of OneRF(TM) Ablation System
stockhouse.com - March 28 at 3:16 PM
NeuroOne begins neuroablation system launch in U.S.NeuroOne begins neuroablation system launch in U.S.
massdevice.com - March 27 at 11:04 AM
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation SystemNeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
finance.yahoo.com - March 26 at 10:19 AM
Neuroone Medical Technologies Corp (NMTC)Neuroone Medical Technologies Corp (NMTC)
investing.com - March 22 at 11:04 PM
NMTC Jul 2024 2.500 callNMTC Jul 2024 2.500 call
ca.finance.yahoo.com - March 17 at 8:55 PM
NeuroOne® to Participate in the 36th Annual Roth ConferenceNeuroOne® to Participate in the 36th Annual Roth Conference
globenewswire.com - March 8 at 12:00 PM
NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - February 24 at 8:52 AM
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - February 23 at 5:10 PM
NeuroOne Medical Technologies Corp: NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNeuroOne Medical Technologies Corp: NeuroOne Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - February 16 at 11:11 AM
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2024 Earnings Call TranscriptNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2024 Earnings Call Transcript
finance.yahoo.com - February 16 at 11:11 AM
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call TranscriptNeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
seekingalpha.com - February 16 at 12:01 AM
NeuroOne Medical Technologies Corporation Registered ShsNeuroOne Medical Technologies Corporation Registered Shs
markets.businessinsider.com - February 15 at 7:00 PM
NeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineNeuroOne Medical Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
finance.yahoo.com - February 15 at 9:00 AM
NeuroOne Medical Technologies GAAP EPS of -$0.14NeuroOne Medical Technologies GAAP EPS of -$0.14
msn.com - February 13 at 5:02 PM
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
finance.yahoo.com - February 13 at 5:02 PM
NeuroOne Medical Technologies earnings: heres what Wall Street expectsNeuroOne Medical Technologies earnings: here's what Wall Street expects
markets.businessinsider.com - February 12 at 3:57 PM
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
finance.yahoo.com - February 8 at 3:55 PM
NeuroOne Medical Technologies Corp.NeuroOne Medical Technologies Corp.
wsj.com - January 24 at 1:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Delcath Systems logo

Delcath Systems

NASDAQ:DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
GlucoTrack logo

GlucoTrack

NASDAQ:GCTK
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
NeuroOne Medical Technologies logo

NeuroOne Medical Technologies

NASDAQ:NMTC
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.